Theresa Heggie

CIK: 0001760020

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)3 (42.9%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BCRX

BIOCRYST PHARMACEUTICALS INC

Director

PRQR

ProQR Therapeutics N.V.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

BCRX
BIOCRYST PHARMACEUTICALS INC
Jun 11, 2026
Award(A)
Direct
15.3K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Mar 20, 2026
Exercise(M)
Direct
49.9K shares at avg. $6.30$315K
BCRX
BIOCRYST PHARMACEUTICALS INC
Mar 20, 2026
Sale(S)
Direct
49.9K shares at avg. $10.11$505K
BCRX
BIOCRYST PHARMACEUTICALS INC
Aug 13, 2025
Exercise(M)
Direct
40K shares at avg. $5.41$216K
BCRX
BIOCRYST PHARMACEUTICALS INC
Aug 13, 2025
Sale(S)
Direct
70K shares at avg. $8.51$596K
BCRX
BIOCRYST PHARMACEUTICALS INC
Aug 13, 2025
Exercise(M)
Direct
30K shares at avg. $2.91$87K
BCRX
BIOCRYST PHARMACEUTICALS INC
Jun 12, 2025
Award(A)
Direct
12.5K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	15,294	-	$0	Direct
Mar 20, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Exercise(M)	49,933	$6.30	$314,578	Direct
Mar 20, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	49,933	$10.11	$504,823	Direct
Aug 13, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Exercise(M)	40,000	$5.41	$216,400	Direct
Aug 13, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	70,000	$8.51	$595,868	Direct
Aug 13, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Exercise(M)	30,000	$2.91	$87,300	Direct
Jun 12, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	12,500	-	-	Direct

1-7 of 7 transactions

About HEGGIE THERESA

HEGGIE THERESA (SEC CIK 0001760020) files insider reports with the SEC as Director of BIOCRYST PHARMACEUTICALS INC (BCRX) and Director of ProQR Therapeutics N.V. (PRQR).

Signal8 holds 5 ownership filings by HEGGIE THERESA (1 Form 3, 4 Form 4), filed between Jun 16, 2025 and Jun 15, 2026. Those filings report 7 transactions, from Jun 12, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on HEGGIE THERESA's filings is in DURHAM, NC.

Recent filings by HEGGIE THERESA

Jun 11, 2026: Grant or award of BCRX shares (Form 4, code A).
Mar 20, 2026: Option exercise of BCRX shares (Form 4, code M).
Mar 20, 2026: Open-market sale of BCRX shares (Form 4, code S).
Aug 13, 2025: Option exercise of BCRX shares (Form 4, code M).
Aug 13, 2025: Open-market sale of BCRX shares (Form 4, code S).

Other insiders filing for BIOCRYST PHARMACEUTICALS INC (BCRX)

Stonehouse Jon P, Director
Milne Jill C., Director
MILANO VINCENT, Director
McKee Amy E, Director
Frank Steven, Director
Galson Steven K, Director

How to read Form 4 transaction codes